Related Articles
MicroRNA‑200c reverses drug resistance of human gastric cancer cells by targeting regulation of the NER‑ERCC3/4 pathway
ERCC1 siRNA ameliorates drug resistance to cisplatin in gastric carcinoma cell lines
The effects of ERCC1 expression levels on the chemosensitivity of gastric cancer cells to platinum agents and survival in gastric cancer patients treated with oxaliplatin‑based adjuvant chemotherapy
Downregulation of microRNA-17-5p inhibits drug resistance of gastric cancer cells partially through targeting p21
MicroRNA‑362‑5p enhances the cisplatin sensitivity of gastric cancer cells by targeting suppressor of zeste 12 protein